Dr. Jeremy Walter Peck, MD, PhD

Dr. Peck practices at Trios Southridge Hospital in Kennewick, Washington, part of Lifepoint Health.

Dr. Peck's NPI, 1457514689, was assigned on July 8, 2008. Dr. Peck graduated from Perelman School of Med at the University of Pennsylvania in 2007. Dr. Peck holds Washington license MD60343797.

Dr. Peck's primary practice is Trios Southridge Hospital, at 3780 Plaza Way, Kennewick, WA 99338 in Benton County. The practice phone is (509) 586-6111. Dr. Peck also practices at Trios Southridge Hospital, 3810 Plaza Way, Kennewick, WA 99338.

Dr. Peck's primary practice is Trios Southridge Hospital in Kennewick, Washington, part of Lifepoint Health. Dr. Peck is also affiliated with Kadlec Regional Medical Center. The medical group on file is Tri-City Dermatology. Dmand AI also links Dr. Peck to 2 more group practices and clinics, 2 medical groups and 1 clinical lab, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Peck practices, 5 sites in all. Vendor and product names are available with a free account.

Mohs-micrographic surgery is Dr. Peck's primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dr. Peck is licensed in Washington.

CMS data shows 5,855 Medicare services from Dr. Peck across 29 procedure codes in 2024, for 1,476 Medicare patients. Medicare paid $391,774 for them. Every service was in an office.

CMS counts 1,476 Medicare patients who saw Dr. Peck in 2024. The largest group is 65 to 74, with 709 patients. 71% of them have high cholesterol, and 65% have high blood pressure. 2% are also on Medicaid. Their average risk score is 0.98, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Peck's median patient age at 72, with 45% women.

In 2024, Dr. Peck wrote 1,217 Medicare Part D claims for 525 patients. 90% of them were for generic drugs. CMS names the drug for 1,085 of them, across 19 drugs with 11 or more claims each, at $725,171 in total drug cost. In 2023, CMS named 862 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Peck for performance year 2024, reported individually. Dr. Peck accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 1,961 procedures of removal of skin lesions by Dr. Peck, more than 98% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 992 general payments to Dr. Peck from 38 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 52% of the total. Galderma Laboratories, L.P. paid the most, $23,378. It also lists 1 research payment totaling $107 in 2018.

Dr. Peck graduated from Perelman School of Med at the University of Pennsylvania in 2007.